Allogenic human umbilical cord derived mesenchymal stem cell (Thousand Stone Biotech)

人脐带间充质干细胞（千石生物科技）

Report date: 2026/05/20 14:55:36

Base Information

Drug NameAllogenic human umbilical cord derived mesenchymal stem cell (Thousand Stone Biotech)

Drug Alias Name赫帕托赛Hepavocel

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesThousand Stone Biotechnology (Shanghai) Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesThousand Stone Biotechnology (Shanghai) Co Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A